Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
Publication
, Journal Article
Wyatt, CM; Drueke, TB
Published in: Kidney Int
April 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
April 2020
Volume
97
Issue
4
Start / End Page
639 / 642
Location
United States
Related Subject Headings
- Urology & Nephrology
- Renal Insufficiency, Chronic
- Renal Dialysis
- Prolyl Hydroxylases
- Isoquinolines
- Humans
- Glycine
- Anemia
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wyatt, C. M., & Drueke, T. B. (2020). Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. Kidney Int, 97(4), 639–642. https://doi.org/10.1016/j.kint.2019.12.005
Wyatt, Christina M., and Tilman B. Drueke. “Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.” Kidney Int 97, no. 4 (April 2020): 639–42. https://doi.org/10.1016/j.kint.2019.12.005.
Wyatt CM, Drueke TB. Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. Kidney Int. 2020 Apr;97(4):639–42.
Wyatt, Christina M., and Tilman B. Drueke. “Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.” Kidney Int, vol. 97, no. 4, Apr. 2020, pp. 639–42. Pubmed, doi:10.1016/j.kint.2019.12.005.
Wyatt CM, Drueke TB. Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. Kidney Int. 2020 Apr;97(4):639–642.
Published In
Kidney Int
DOI
EISSN
1523-1755
Publication Date
April 2020
Volume
97
Issue
4
Start / End Page
639 / 642
Location
United States
Related Subject Headings
- Urology & Nephrology
- Renal Insufficiency, Chronic
- Renal Dialysis
- Prolyl Hydroxylases
- Isoquinolines
- Humans
- Glycine
- Anemia
- 3202 Clinical sciences
- 1103 Clinical Sciences